Showing results (161-170 of 545) with videos related to
Sort By:
Pageof 55
Archives of Disease in Childhood|April 1, 1985
Ceftazidime in neonatal infectionsD C Low, J G Bissenden, R WiseAntimicrobial Agents and Chemotherapy|August 1, 1988
In vitro activity of PD 127,391, an enhanced-spectrum quinoloneR Wise, J P Ashby, J M AndrewsThe Journal of Antimicrobial Chemotherapy|April 9, 1998
Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effectF J Boswell, J M Andrews, R WiseChemotherapy|January 1, 1977
The activity of four antimicrobial agents. Including three nitroimidazole compounds, against Bacteroides spR Wise, J M Andrews, K A BedfordThe Journal of Antimicrobial Chemotherapy|November 1, 1987
Factors affecting the in-vitro activity of roxithromycinJ M Andrews, J P Ashby, R WiseAntimicrobial Agents and Chemotherapy|February 1, 1987
In vitro activity of CGP 31608, a new penemR Wise, J M Andrews, L J PiddockThe Journal of Antimicrobial Chemotherapy|June 22, 2001
Concentrations of gatifloxacin in plasma and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopyD Honeybourne, D Banerjee, J Andrews, et al.The Journal of Antimicrobial Chemotherapy|March 1, 1990
The accumulation of five quinolone antibacterial agents by Escherichia coliJ M Diver, L J Piddock, R WiseJournal of the American College of Nutrition|February 1, 1996
Vitamin E and vitamin E-quinone levels in red blood cells and plasma of newborn infants and their mothersS K Jain, R Wise, J J BocchiniAntimicrobial Agents and Chemotherapy|April 1, 1983
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsR Wise, J M Andrews, L J EdwardsPageof 55